AIDS drug trials attackedBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7089.1217i (Published 26 April 1997) Cite this as: BMJ 1997;314:1217
- Jacqui Wise
The design of clinical trials for AIDS drug treatments have been sharply criticised by an AIDS researcher.
Joep Lange, from the national AIDS therapy evaluation centre in Amsterdam, says that too often suboptimal drug treatments are still being used, both in the treatment of patients with AIDS and in clinical trials (Science 1997;276:548-50). This is partly because regulatory requirements often dictate …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial